Last updated 2026-09-03
- Raised Seed round led by Peregrine Ventures, Aug 2024
Total raised
—
Last: Undisclosed Round 2024-07
Stage
Seed
Founded
2022
Headcount
7
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences
About
Kanso Diagnostics is an Israeli startup that aims to revolutionize molecular diagnostics by providing affordable, lab-grade tests that are accessible anywhere, operable by anyone, and deliver results in minutes. Their novel platform can accurately detect multiple pathogens and genetic biomarkers from a single sample, reducing diagnosis time from days to minutes. The technology offers PCR-grade accuracy with the convenience of rapid home testing, providing an end-to-end solution for diagnosing bacterial and viral infections anytime, anywhere. The first product addresses the critical need for rapid and accurate detection of sexually transmitted infections (STIs), including the detection of antimicrobial resistance (AMR).
Funding history · 1 round · — total
1 event/round · — Total Funding
Aug 2024
Headcount over time
7 employees (2026-09) · 1 point
Offices
Or Yehuda, Israel · HQ / main office
Q&A
- What is Kanso Diagnostics' primary focus?
- Kanso Diagnostics develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need, aiming to provide affordable and accessible tests that deliver results in minutes.
- When was Kanso Diagnostics founded?
- Kanso Diagnostics was founded in March 2022.
- How many employees does Kanso Diagnostics currently have?
- Kanso Diagnostics has 10 employees, which falls within the 1-10 employee bucket.
- What is the total amount of funding Kanso Diagnostics has raised to date?
- Kanso Diagnostics has raised a total of $2,000,000 USD.
- Who are the co-founders of Kanso Diagnostics?
- The co-founders of Kanso Diagnostics are Roy Rabinowitz, who serves as CEO, and Omer Stoller, who is the CTO.
- What is the latest funding round Kanso Diagnostics received?
- Kanso Diagnostics received a Grant round in July 2024.
- What is Kanso Diagnostics' current product stage?
- Kanso Diagnostics' product is currently in the alpha stage.
Team · 7
Dr. Roy Rabinowitz
Founder · Co-founder, Chief Executive Officer
Omer Stoller
Founder · Co-founder, Chief Technology Officer
Prof. Yoav Golan
Chief Medical Officer
Dr. Shakked Halperin
Chief Scientific Officer
Dr. Yuval Nash
Head of biology
Shahaf Sigal Dror
Clinical dev. assistant
Dr. Shosh Zismanov
R&D scientist
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B
Highlights
1 PatentsVerified
Tags
molecular-biologydiagnosticsinfectious-diseasebiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | kansodx.com |
|---|---|
| linkedin.com/company/86834526 |
Identifiers & details
| Legal name | KANSO DIAGNOSTICS LTD |
|---|---|
| Founded | 2022-3 |
| Employees (exact) | 7 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | kansodx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516574464 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-03-06 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 3 — people (1), annual_report (2) |
| Registered address | נתניהו יהונתן 6 אור יהודה |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-23 | עדכון בעלי תפקידים |
| 2026-01-20 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-01-20 | דו~ח שנתי-הוספת בעל תפקיד |